Bergapten alleviates Parkinson's disease-like behaviors in mice by inhibiting astrocyte inflammatory activation and endoplasmic reticulum stress through the regulation of the LCN2/JAK2/STAT3 pathway
Background: Parkinson's disease (PD) is a common neurodegenerative disorder involving multiple pathological processes. Bergapten (BeG) exhibits various pharmacological activities, including anti-inflammatory, antioxidant, and neuroprotective effects, but its mechanism of action in PD remains unclear...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
University of Karachi
2026-01-01
|
| Colección: | Pakistan Journal of Pharmaceutical Sciences |
| Acceso en línea: | https://pjps.pk/single-article?id=cmr82c0nv00015ca34645fira |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|